Brief: Moleculin Reports Full Year 2023 Financial Results
22/03/2024 20:10
March 22 (Reuters) - Moleculin Biotech Inc MBRX.O :
* MOLECULIN REPORTS FULL YEAR 2023 FINANCIAL RESULTS
* MOLECULIN BIOTECH INC- AS OF DECEMBER 31, 2023, COMPANY
HAD CASH
AND CASH EQUIVALENTS OF $23.6 MILLION
Source text for Eikon: ID:nPn2Bl3K1a
Further company coverage: MBRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Moleculin Biotech
See all newsMoleculin Biotech Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Moleculin Secures Australian Patent For Annamycin Formulation Technology
Moleculin Biotech Inc expected to post a loss of $8.87 a share - Earnings Preview
Brief: Moleculin Biotech Completes Dosing In Part A Of Miracle Trial Data Readout On Track For Q1 2027
NASDAQ RESUMED AT 09:00 AM